Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steinbach

Showing results (171-180 of 369) with videos related to

Pageof 37
Sort By:
Urologia Internationalis|January 1, 1995
Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasiasM Kriegmair, H Stepp, P Steinbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent gliomaAntje Wick, Jörg Felsberg, Joachim P Steinbach, et al.
British Journal of Cancer|January 1, 1997
Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cellsH Messmann, M Geisler, U Gross, et al.
Human Genetics|November 1, 1993
Molecular analysis of mutations in the gene FMR-1 segregating in fragile X familiesP Steinbach, D Wöhrle, G Tariverdian, et al.
British Journal of Cancer|February 13, 2019
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastomaMartha Foltyn, Anna-Luisa Luger, Nadja I Lorenz, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2022
Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatmentMarie-Therese Forster, Marion Hug, Maximilian Geissler, et al.
Clinical Genetics|July 1, 1986
Dermatoglyphic peculiarities in families with X-linked mental retardation and fragile site Xq27: a collaborative studyA Rodewald, U Froster-Iskenius, E Käb, et al.
Brain : a Journal of Neurology|May 7, 2009
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell deathMichael W Ronellenfitsch, Daniel P Brucker, Michael C Burger, et al.
Frontiers in Immunology|December 5, 2019
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer ImmunotherapyMichael C Burger, Congcong Zhang, Patrick N Harter, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three PatientsAgnes Koch, Stefan Sponholz, Stephan Trainer, et al.
Pageof 37

Showing results (171-180 of 369) with videos related to

Sort By:
Pageof 37
Urologia Internationalis|January 1, 1995
Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasiasM Kriegmair, H Stepp, P Steinbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent gliomaAntje Wick, Jörg Felsberg, Joachim P Steinbach, et al.
British Journal of Cancer|January 1, 1997
Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cellsH Messmann, M Geisler, U Gross, et al.
Human Genetics|November 1, 1993
Molecular analysis of mutations in the gene FMR-1 segregating in fragile X familiesP Steinbach, D Wöhrle, G Tariverdian, et al.
British Journal of Cancer|February 13, 2019
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastomaMartha Foltyn, Anna-Luisa Luger, Nadja I Lorenz, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2022
Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatmentMarie-Therese Forster, Marion Hug, Maximilian Geissler, et al.
Clinical Genetics|July 1, 1986
Dermatoglyphic peculiarities in families with X-linked mental retardation and fragile site Xq27: a collaborative studyA Rodewald, U Froster-Iskenius, E Käb, et al.
Brain : a Journal of Neurology|May 7, 2009
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell deathMichael W Ronellenfitsch, Daniel P Brucker, Michael C Burger, et al.
Frontiers in Immunology|December 5, 2019
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer ImmunotherapyMichael C Burger, Congcong Zhang, Patrick N Harter, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three PatientsAgnes Koch, Stefan Sponholz, Stephan Trainer, et al.
Pageof 37